Viral Hepatitis

123456789101112131415
Across
  1. 1. All patients should be tested for ______ prior to starting Hep B therapy
  2. 3. Sofosbuvir/velpatasvir
  3. 5. Hep B and C transmission occurs from contact with infectious_________ and other bodily fluids
  4. 7. Term for working against all genotypes
  5. 11. Initial diagnostic testing for Hep C
  6. 12. Transmission of this hepatitis virus is primarily via the fecal-oral route through improper hand-washing
  7. 13. All DAAs are contraindicated with CYP3A4
  8. 14. Treatment class for Hep B
  9. 15. Abbreviation for Hep B drug with risk of nephrotoxicity, osteomalacia, and Fanconi syndrome
Down
  1. 1. Boxed warning for entire class of DAAs: Risk of reactivating ______
  2. 2. First-line treatment for Hep A
  3. 4. Epclusa, Harvoni, and Vosevi: Avoid or minimize ______ suppressive therapy during treatment
  4. 6. Hepatitis means ______ of the liver
  5. 7. Mavyret is composed of glecaprevir and
  6. 8. Most DAAs increase concentrations of ______, increasing risk for myopathy
  7. 9. Contraindicated in moderate-severe hepatic impairment (Child Pugh B or C) or history of hepatic decompensation
  8. 10. Mavyret must be taken with
  9. 12. No vaccine available for this hepatitis virus